POLYPID LTDNARY SHARES
Share · IL0011326795 · PYPD (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of POLYPID LTDNARY SHARES
No Price
29.04.2026 19:42
Current Prices from POLYPID LTDNARY SHARES
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
NASDAQ |
PYPD
|
USD
|
29.04.2026 19:42
|
4,55 USD
| 0,12 USD
+2,71 %
|
IEX |
PYPD
|
USD
|
27.04.2026 14:28
|
4,73 USD
| - |
Company Profile for POLYPID LTDNARY SHARES Share
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Company Data
Name POLYPID LTDNARY SHARES
Company PolyPid Ltd.
Symbol PYPD
Website
https://www.polypid.com
Primary Exchange
NASDAQ
NASDAQ
ISIN IL0011326795
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dikla Czaczkes Akselbrad
Market Capitalization 45 Mio
Country Israel
Currency USD
Employees 0,1 T
Address 18 Hasivim Street, 4959376 Petah Tikva
IPO Date 2020-06-26
Stock Splits
| Date | Split |
|---|---|
| 21.09.2023 | 1:30 |
ID Changes
| Date | From | To |
|---|---|---|
| 26.06.2020 | POLY | PYPD |
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 2PV.F |
| NASDAQ | PYPD |
More Shares
Investors who hold POLYPID LTDNARY SHARES also have the following shares in their portfolio:

